Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

In a report released today, Charles Rhyee from TD Cowen maintained a Buy rating on CVS Health (CVS – Research Report), with a price target of ...

A GoLocal investigation explores how CVS and its then-President Helena Foulkes often told one story about opioids while the company profited, and she made tens of millions in salary, stock incentives, ...

Independent drugstores are closing at an alarming rate — about one a day in 2023 — squeezed by the huge companies that ...

Two weeks into the job, it’s clear that newly elected State Treasurer Brad Briner won’t shy away from taking action, even if ...

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

The 3 largest pharmacy benefit managers (PBMs) increased many specialty generic drugs prices by hundreds of percent, with ...

The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...

Between 2017 and 2022, UnitedHealth Group’s Optum, Cigna’s Express Scripts and CVS Health’s CVS Caremark marked up their ...